Unraveling the role of cancer-associated fibroblasts in B cell lymphoma
Open Access
- 1 November 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1451791
Abstract
Recent breakthroughs in research have sparked a paradigm shift in our understanding of cancer biology, uncovering the critical role of the crosstalk between tumor cells and the immune cells of the tumor microenvironment (TME) in malignant transformation. Fibroblasts have long been viewed as ancillary participants in cancer progression, often eclipsed by the prominence given to malignant cells. Novel investigations, however, have increasingly acknowledged the essential part played by the fibroblasts and their phenotypic doppelganger cancer-associated fibroblasts (CAFs) in fostering immunosuppression and promoting tumor progression. Here we review the cell-of-origin from which CAFs derive and their altered programs compared to their normal counterpart. We will also discuss the complex interplay between CAFs and the surrounding immune cells of the TME in the context of solid tumors and B cell lymphomas, with a focus on the “reprogrammable” role of CAFs in immunosuppression, immuno-activation and immuno-avoidance, and their implications on drug resistance. Finally, we will examine the existing and plausible therapeutic approaches targeting CAFs as a strategy to enhance treatment response.Keywords
This publication has 115 references indexed in Scilit:
- Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patientsCancer Cell, 2024
- Metabolic Relationship Between Cancer-Associated Fibroblasts and Cancer Cells2021
- Cancer Associated Fibroblasts: The Architects of Stroma RemodelingProteomics, 2018
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell LymphomaCancer Cell, 2011
- CD80 (B7.1) is expressed on both malignant B cells and nonmalignant stromal cells in non‐Hodgkin lymphomaCytometry Part B: Clinical Cytometry, 2011
- Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent MannerCancer Cell, 2010
- CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell culturesCytotechnology, 2009
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF TreatmentCancer Cell, 2009
- Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in miceCancer Cell, 2005
- Germinal centre‐like versus undifferentiated stromal immunophenotypes in follicular lymphomaThe Journal of Pathology, 2003